Insider Monkey
Jim Cramer on Bristol-Myers’ Recent Stock Gain: “Unbelievable”
➖
AI Sentiment
Neutral
5/10
- Home
- LLY
as of 12-05-2025 3:57pm EST
$1,007.40
$2.63
-0.26%
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Chart Type:
Time Range:
| Founded: | 1876 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 948.5B | IPO Year: | N/A |
| Target Price: | $1063.44 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 20.44 | EPS Growth: | 121.02 |
| 52 Week Low/High: | $623.78 - $1111.99 | Next Earning Date: | 10-30-2025 |
| Revenue: | $59,419,800,000 | Revenue Growth: | 45.41% |
| Revenue Growth (this year): | 42.59% | Revenue Growth (next year): | 19.62% |
AI-Powered LLY Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 74.19%
74.19%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Eli Lilly and Company (LLY)
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 25, 2025
Avg Cost/Share
$1,093.76
Shares
162,693
Total Value
$178,423,264.13
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 24, 2025
Avg Cost/Share
$1,070.96
Shares
142,307
Total Value
$152,058,090.84
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 21, 2025
Avg Cost/Share
$1,058.46
Shares
105,326
Total Value
$111,504,097.67
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 19, 2025
Avg Cost/Share
$1,052.87
Shares
167,526
Total Value
$176,098,702.11
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 18, 2025
Avg Cost/Share
$1,035.01
Shares
60,213
Total Value
$62,306,968.56
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 17, 2025
Avg Cost/Share
$1,030.99
Shares
19,772
Total Value
$20,378,538.99
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 14, 2025
Avg Cost/Share
$516,449.12
Shares
178,295
Total Value
$75,907,041,786.85
Owned After
92,284,393
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 13, 2025
Avg Cost/Share
$1,030.99
Shares
46,606
Total Value
$48,016,098.38
Owned After
92,284,393
Zakrowski Donald A
Sell
SVP, Finance, & CAO
LLY Nov 13, 2025
Avg Cost/Share
$1,010.50
Shares
1,000
Total Value
$1,010,500.00
Owned After
2,839.659
SEC Form 4
LILLY ENDOWMENT INC
Sell
10% Owner
LLY Nov 12, 2025
Avg Cost/Share
$1,011.53
Shares
305,000
Total Value
$308,411,204.36
Owned After
92,284,393
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 25, 2025 | Sell | $1,093.76 | 162,693 | $178,423,264.13 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 24, 2025 | Sell | $1,070.96 | 142,307 | $152,058,090.84 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 21, 2025 | Sell | $1,058.46 | 105,326 | $111,504,097.67 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 19, 2025 | Sell | $1,052.87 | 167,526 | $176,098,702.11 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 18, 2025 | Sell | $1,035.01 | 60,213 | $62,306,968.56 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 17, 2025 | Sell | $1,030.99 | 19,772 | $20,378,538.99 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 14, 2025 | Sell | $516,449.12 | 178,295 | $75,907,041,786.85 | 92,284,393 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 13, 2025 | Sell | $1,030.99 | 46,606 | $48,016,098.38 | 92,284,393 | |
| Zakrowski Donald A | LLY | SVP, Finance, & CAO | Nov 13, 2025 | Sell | $1,010.50 | 1,000 | $1,010,500.00 | 2,839.659 | |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Nov 12, 2025 | Sell | $1,011.53 | 305,000 | $308,411,204.36 | 92,284,393 |
Latest Eli Lilly and Company News
LLY Breaking Stock News: Dive into LLY Ticker-Specific Updates for Smart Investing
Motley Fool
Do These 3 Healthcare Stocks Need a Checkup?
Motley Fool
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Nvidia, Palantir AWOL, But Top Funds Go Bonkers For This AI Mobilizer
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Eli Lilly, Alphabet Among Megacap Leaders On This Growth List
📊
AI Sentiment
Positive
7/10
Investor's Business Daily
Dow Jones Futures Rise; Netflix To Buy Warner Bros
📊
AI Sentiment
Positive
7/10
Zacks
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Is It Too Late To Consider Eli Lilly After Its Massive Five Year Share Price Surge?
📊
AI Sentiment
Positive
7/10
Compare LLY vs Leading Stocks
See how LLY stacks up against similar companies in the market
Head-to-Head Comparisons
More Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LLY Eli Lilly and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.